Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ryoko YADA"'
Autor:
Ryo Miyake, Kisho Ohtani, Toru Hashimoto, Ryoko Yada, Tasuku Sato, Yoko Shojima, Shunji Hayashidani, Taiki Higo, Hiroyuki Tsutsui
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 1145-1149 (2020)
Abstract Takotsubo syndrome (TTS), also referred to as stress cardiomyopathy, is characterized by transient left ventricular apical ballooning in the absence of obstructive coronary artery disease. Catecholamine‐induced cardiac injury or vasospasm
Externí odkaz:
https://doaj.org/article/994a590d9db84e3cb26eef6e33d8ff74
Autor:
Kazuhiro MIYAZAKI, Yuichi SAKAMOTO, Shiho SATO, Ryouhei MIYAMOTO, Ryoko YADA, Hideyuki ISHII, Takahiro YAMAUCHI, Fumikazu GOTO, Akihiko KINOSHITA, Shinya KANEKO, Satomi MATSUSHITA-ASANO, Yasumasa MIYAZAKI, Erika OKII, Susumu SHIRAISHI
Publikováno v:
Mushroom Science & Biotechnology; 2024, Vol. 32 Issue 1, p31-40, 10p
Autor:
Yoko Shojima, Ryo Miyake, Shunji Hayashidani, Taiki Higo, Hiroyuki Tsutsui, Ryoko Yada, Kisho Ohtani, Tasuku Sato, Toru Hashimoto
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 3, Pp 1145-1149 (2020)
ESC Heart Failure, Vol 7, Iss 3, Pp 1145-1149 (2020)
Takotsubo syndrome (TTS), also referred to as stress cardiomyopathy, is characterized by transient left ventricular apical ballooning in the absence of obstructive coronary artery disease. Catecholamine‐induced cardiac injury or vasospasm has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ca1ba4970e2004fb9233d454892f8b
https://doi.org/10.1002/ehf2.12632
https://doi.org/10.1002/ehf2.12632
Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism
Autor:
Masaki Kato, Atsushi Nakajima, Yuichi Nozaki, Tsukasa Nakamura, Kunitaka Fukuizumi, Kazuhiro Kotoh, Ryoko Yada, Makoto Nakamuta, Yoshihiko Maehara, Motoyuki Kohjima, Yusuke Murata, Ken Shirabe, Akira Honda, Nobuyoshi Fukushima, Tsuyoshi Yoshimoto, Munechika Enjoji, Manabu Nakashima, Yasushi Matsuzaki
Publikováno v:
Liver International. 35:1095-1102
Background & Aims Injury to biliary epithelial cells caused by disorders in bile composition may be the initial step in the pathogenesis of primary biliary cirrhosis (PBC). We therefore examined choline/phospholipid metabolism in livers of patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67dad025a14bc202fbd920c162e45284
https://doi.org/10.1111/liv.12526
https://doi.org/10.1111/liv.12526
Autor:
Yasuhito Tanaka, Kazuhiro Kotoh, Makoto Nakamuta, Tsuyoshi Yoshimoto, Motoyuki Kohjima, Munechika Enjoji, Kunitaka Fukuizumi, Yoko Aoyagi, Manabu Nakashima, Naoya Sakamoto, Tatsuya Fujino, Masayoshi Yada, Masaki Kato, Naohiko Harada, Nobuyoshi Fukushima, Ryoko Yada
Publikováno v:
Journal of Medical Virology. 85:250-260
Despite the use of pegylated-interferon (peg-IFN) plus ribavirin combination therapy, many patients infected with hepatitis C virus (HCV)-1b remain HCV-positive. To determine whether addition of pitavastatin and eicosapentaenoic acid (EPA) is benefic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c442829c2f292f1f0fbd73fbf0d8ce
https://doi.org/10.1002/jmv.23464
https://doi.org/10.1002/jmv.23464
Autor:
Munechika Enjoji, Y. Maehara, Tsuyoshi Yoshimoto, Naohiko Harada, Yoko Aoyagi, Manabu Nakashima, Kazuhiro Kotoh, Motoyuki Kohjima, Masaki Kato, Ryoko Yada, Kunitaka Fukuizumi, Akinobu Taketomi, Masayoshi Yada, M. Nakamuta, Tatsuya Fujino, Kenichiro Yasutake
Publikováno v:
Journal of Medical Virology. 83:921-927
Recent studies have demonstrated that several cellular factors are involved in entry of hepatitis C virus (HCV) into host cells. Detailed gene expression profiles of these factors in HCV-infected livers have not been reported for humans. Transcriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58005bd433f561b9296314868b59fa84
https://doi.org/10.1002/jmv.22042
https://doi.org/10.1002/jmv.22042
Autor:
Masayoshi Yada, Makoto Nakamuta, Nobito Higuchi, Munechika Enjoji, Tatsuya Fujino, Akinobu Taketomi, Kazuhiro Kotoh, Motoyuki Kohjima, Ryoko Yada, Masaki Kato, Naohiko Harada, Yoshihiko Maehara, Tsuyoshi Yoshimoto, Manabu Nakashima
Publikováno v:
Hepatology International. 3:490-496
Because dyslipidemia, such as hypercholesterolemia, is a characteristic of primary biliary cirrhosis (PBC), hepatic lipid metabolism may be disturbed in PBC patients. We examined the expression of lipid metabolism-associated genes in PBC liver.All of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfec4d11d56308f4735adcb84f123512
https://doi.org/10.1007/s12072-009-9137-y
https://doi.org/10.1007/s12072-009-9137-y
Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes
Autor:
Takuya Nishinakagawa, Goshi Shiota, Mako Toyoda, Kazuhiro Kotoh, Akira Kitaoka, Manabu Nakashima, Makoto Nakamuta, Masaki Kato, Ryoko Yada, Motoyuki Kohjima, Munechika Enjoji, Naoya Sakamoto, Kazuyuki Machida
Publikováno v:
International Journal of Molecular Medicine. 27
Evidence from clinical and laboratory studies has accumulated indicating that the activation of the cannabinoid system is crucial for steatosis, especially in non-alcoholic fatty liver disease. However, the association between hepatitis C virus (HCV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91f8e80d0d2cf8d7e31c802309592c3
https://doi.org/10.3892/ijmm.2011.622
https://doi.org/10.3892/ijmm.2011.622
Autor:
Tatsuya, Fujino, Makoto, Nakamuta, Ryoko, Yada, Yoko, Aoyagi, Kenichiro, Yasutake, Motoyuki, Kohjima, Kunitaka, Fukuizumi, Tsuyoshi, Yoshimoto, Naohiko, Harada, Masayoshi, Yada, Masaki, Kato, Kazuhiro, Kotoh, Akinobu, Taketomi, Yoshihiko, Maehara, Manabu, Nakashima, Munechika, Enjoji
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 40(9)
Recent studies have shown that lipid metabolic pathways are required for the entry, replication and secretion of hepatitis C virus (HCV). Although little is known about the life cycle of HCV in humans, the activation of cholesterol and fatty acid bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c773ffad9bdaeaf342b12858b7177725
https://pubmed.ncbi.nlm.nih.gov/20887597
https://pubmed.ncbi.nlm.nih.gov/20887597
Autor:
Akinobu Taketomi, Tsuyoshi Yoshimoto, Motoyuki Kohjima, Manabu Nakashima, Makoto Nakamuta, Tatsuya Fujino, Kazuhiro Kotoh, Naohiko Harada, Yoshihiko Maehara, Munechika Enjoji, Nobito Higuchi, Masaki Kato, Kazuyuki Machida, Masayoshi Yada, Ryoko Yada, Kenichiro Yasutake, Kazuhisa Matsunaga, Takuya Nishinakagawa
Publikováno v:
International journal of clinical pharmacology and therapeutics. 48(1)
Objective Bezafibrate (BF) has been used to treat biliary damage, particularly in patients with primary biliary cirrhosis (PBC), and its clinical efficacy has been demonstrated. The mechanism of action is thought to involve activation of the PPARalph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9497c6489af3ec8c2313b6dbd7844acf
https://pubmed.ncbi.nlm.nih.gov/20040336
https://pubmed.ncbi.nlm.nih.gov/20040336